These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 34564609)

  • 1. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin therapy in treatment of myofascial pain.
    Chaurand J; Pacheco-Ruíz L; Orozco-Saldívar H; López-Valdés J
    J Oral Sci; 2017; 59(3):351-356. PubMed ID: 28904310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporomandibular disorders in patients with craniocervical dystonia.
    Costa AL; Campos LS; França MC; D'Abreu A
    Arq Neuropsiquiatr; 2011 Dec; 69(6):896-9. PubMed ID: 22297875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
    Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
    Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE; Smith A; Hawkins JM
    Clin Neuropharmacol; 2020; 43(5):162-163. PubMed ID: 32947428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.
    Yoshida K; Iizuka T
    Cranio; 2006 Jul; 24(3):217-22. PubMed ID: 16933464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
    Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
    J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.